Kaufman Joel H. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Nov 6, 2020
Insider Transaction Report
Form 4
Kaufman Joel H.
Chief Business Officer
Transactions
- Award
Stock Option
2020-11-04$0.00/sh+20,000$20→ 20,000 totalExercise: $2.31Exp: 2030-11-04→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Stock options granted pursuant to the Issuer's Amended and Restated 2014 Stock Incentive Plan, which vest as to one-third (1/3) on each of the first three anniversaries of the date of grant.